Full Target Reached at $54: Take Profit on ALPS Medical Breakthroughs ETF (Running +32%)

Research Notes January 2026 > https://www.unum.capital/post/rjan2026

Trade Local & Global Financial Markets with Unum Capital.

To get started, email tradingdesk@unum.co.za

---

Previous Post (09 October) BUY IDEA: The ALPS Medical Breakthroughs ETF (SBIO) provides exposure to small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the US Food and Drug Administration clinical trials. Constituents must have a market capitalization of no less than $200 million and no more than $5 billion.

Buy: $40.89 (or better/lower)

Stop-loss: $36.20

Target: $50.00, $54.00

Lester Davids

Senior Investment Analyst: Unum Capital